CAS
FLNA

CTC Alternative Strategies’s Filana Therapeutics FLNA Stock Holding History

CTC Alternative Strategies’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,629
Closed -$62.7K – 253
2014
Q1 		$62.7K Buy
+1,629
New +$57.5K 0.04% 144
2013
Q3 		– Sell
-1,629
Closed -$25.2K – 180
2013
Q2 		$25.2K Buy
+1,629
New +$34.4K 0.01% 194

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CTC Alternative Strategies's FLNA Position: Q2 2014 in Review

CTC Alternative Strategies sold out of Filana Therapeutics (FLNA) in Q2 2014, closing a stake of 1,629 shares — an estimated $62.7K sold.

CTC Alternative Strategies first reported a position in FLNA in Q2 2013 and held it in 2 quarters. The position peaked at $62.7K in Q1 2014. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2014.

  • CTC Alternative Strategies reported no remaining Filana Therapeutics position as of Q2 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 1,629 Filana Therapeutics shares in Q2 2014, an estimated $62.7K.
  • CTC Alternative Strategies first reported a position in Filana Therapeutics in Q2 2013 and held it in 2 quarters.
  • CTC Alternative Strategies's Filana Therapeutics position peaked at $62.7K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2014.

Based on CTC Alternative Strategies's 13F filing for Q2 2014, filed 22 Jul 2014.